|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Revenue | ||
| Revenues (including sales to a related party of US$406,373, US$1,690,196 and US$753,827 for the years ended December 31, 2023, 2024 and 2025, respectively) | ||
| Cost of revenue | ||
| Cost of revenues (including purchase from a related party of US$70,698, US$428,046 and US$147,611 for the years ended December 31, 2023, 2024 and 2025, respectively) | ||
| Gross profit | ||
| Operating expenses: | ||
| Selling and marketing expenses | ||
| Research and development expenses | ||
| General and administrative expenses | ||
| Total operating expenses | ||
| Government grants | ||
| Operating loss | ||
| Changes in fair value of financial instruments | ||
| Gain on extinguishment of convertible debts | ||
| Interest expenses | ||
| Interest income | ||
| Loss before income taxes | ||
| Net loss | ||
| Accretion of redeemable preference shares to redemption value | ||
| Net loss attributable to ordinary shareholders | ||
| Other comprehensive income (loss) | ||
| Foreign currency translation adjustment, net of nil income taxes | ||
| Total comprehensive loss | ||
| Loss per ordinary share-Basic | ||
| Loss per ordinary share-Diluted | ||
| Weighted average number of ordinary shares-Basic | ||
| Class A and Class B Ordinary Shares | ||
| Total weighted average number of ordinary shares-Basic | ||
| Weighted average number of ordinary shares-Diluted | ||
| Class A and Class B Ordinary Shares | ||
| Total weighted average number of ordinary shares-Diluted |
Loading...
